{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T01:52:11Z","timestamp":1781747531548,"version":"3.54.5"},"reference-count":44,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Gastric adenocarcinoma (STAD) exhibits extensive intratumoral heterogeneity that contributes to tumor progression and therapeutic resistance. In this study, we integrated single-cell RNA sequencing and bulk transcriptomic analyses to characterize malignant epithelial subtypes in STAD. Among seven identified tumor subtypes, the OLFM4-associated C3 subtype exhibited enriched palmitoylation-related signatures and altered metabolic activities, particularly glycolysis-related pathways. Functional enrichment analyses further supported the enrichment of multiple energy metabolism pathways. To evaluate the association between OLFM4 and metabolic regulation, recombinant OLFM4 treatment and siRNA-mediated OLFM4 knockdown were performed in gastric cancer cell lines. OLFM4 upregulation increased the expression of ZDHHC2 and GLUT1, accompanied by enhanced glucose uptake and elevated ATP production, whereas OLFM4 silencing reduced ZDHHC2 and GLUT1 expression. In addition, a prognostic risk model derived from C3 subtype-associated genes (MUC16, RALA, and PCBD1) effectively stratified STAD patients and was associated with immune checkpoint expression and immune infiltration. Collectively, our findings identify an OLFM4-associated gastric cancer cell state with palmitoylation-related signatures and altered metabolic activities, highlighting its potential relevance to metabolic heterogeneity in gastric adenocarcinoma.<\/jats:p>","DOI":"10.3390\/biom16060880","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:49:42Z","timestamp":1781743782000},"page":"880","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-Cell Transcriptomic Analysis Identifies an OLFM4-Associated Gastric Cancer Cell State with Palmitoylation-Related Signatures and Altered Metabolic Activities"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8151-2179","authenticated-orcid":false,"given":"Gong","family":"Chen","sequence":"first","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, University of Heidelberg, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Wei","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Medical Faculty Mannheim, University Medical Centre Mannheim (UMM), Heidelberg University, 68167 Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, University of Heidelberg, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7382-6028","authenticated-orcid":false,"given":"Shanshan","family":"Han","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, University of Heidelberg, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sch\u00e4fer","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, University of Heidelberg, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, University of Heidelberg, 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Lin, J.-L., Lin, J.-X., Lin, G.-T., Huang, C.-M., Zheng, C.-H., Xie, J.-W., Wang, J.-B., Lu, J., Chen, Q.-Y., and Li, P. (2024). Global incidence and mortality trends of gastric cancer and predicted mortality of gastric cancer by 2035. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-19104-6"},{"key":"ref_2","first-page":"113","article-title":"The application of artificial intelligence in upper gastrointestinal cancers","volume":"5","author":"Huang","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: Recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s13402-024-00951-9","article-title":"Research advances in the molecular classification of gastric cancer","volume":"47","author":"Shi","year":"2024","journal-title":"Cell. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/1878-0261.13654","article-title":"Proteome-based molecular subtyping and therapeutic target prediction in gastric cancer","volume":"18","author":"Hu","year":"2024","journal-title":"Mol. Oncol."},{"key":"ref_6","first-page":"52","article-title":"Recent developments in application of single-cell RNA sequencing in the tumour immune microenvironment and cancer therapy","volume":"9","author":"Li","year":"2022","journal-title":"Mil. Med. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/cac2.12078","article-title":"Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy","volume":"40","author":"Ding","year":"2020","journal-title":"Cancer Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e70948","DOI":"10.1002\/cam4.70948","article-title":"Advances in the Study of Metabolic Reprogramming in Gastric Cancer","volume":"14","author":"Rong","year":"2025","journal-title":"Cancer Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zhou, L., Su, B., Shan, Z., Gao, Z., Guo, X., Wang, W., Wang, X., Sun, W., Yuan, S., and Sun, S. (2025). Metabolic Reprogramming of Gastric Cancer Revealed by a Liquid Chromatography\u2013Mass Spectrometry-Based Metabolomics Study. Metabolites, 15.","DOI":"10.3390\/metabo15040222"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41467-025-56344-5","article-title":"Palmitoylation-dependent regulation of GPX4 suppresses ferroptosis","volume":"16","author":"Huang","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"EMBR201846666","DOI":"10.15252\/embr.201846666","article-title":"Protein palmitoylation and cancer","volume":"19","author":"Ko","year":"2018","journal-title":"EMBO Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1038\/s41467-024-49105-3","article-title":"ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1878-0261.13308","article-title":"Protein palmitoylation in cancer: Molecular functions and therapeutic potential","volume":"17","author":"Zhou","year":"2022","journal-title":"Mol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"bgaf010","DOI":"10.1093\/carcin\/bgaf010","article-title":"Olfactomedin 4 promotes gastric cancer cell G2\/M progression and serves as a therapeutic target in gastric adenocarcinoma","volume":"46","author":"Liu","year":"2025","journal-title":"Carcinogenesis"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3748\/wjg.v24.i17.1881","article-title":"Olfactomedin-4 in digestive diseases: A mini-review","volume":"24","author":"Wang","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10543","DOI":"10.1038\/s41467-024-54850-6","article-title":"Epstein-Barr virus infection upregulates extracellular OLFM4 to activate YAP signaling during gastric cancer progression","volume":"15","author":"Wen","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12943-024-02016-9","article-title":"OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9\/GSK3\u03b2\/\u03b2-catenin pathway","volume":"23","author":"Wei","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e2415645","DOI":"10.1002\/advs.202415645","article-title":"Deciphering the Metabolic Impact and Clinical Relevance of N-Glycosylation in Colorectal Cancer through Comprehensive Glycoproteomic Profiling","volume":"12","author":"Liu","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.gastro.2009.05.035","article-title":"OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells","volume":"137","author":"Haegebarth","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/liv.14747","article-title":"LGR5 induces \u03b2-catenin activation and augments tumour progression by activating STAT3 in human intrahepatic cholangiocarcinoma","volume":"41","author":"Kawasaki","year":"2020","journal-title":"Liver Int."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Lin, X., Yang, P., Wang, M., Huang, X., Wang, B., Chen, C., Xu, A., Cai, J., Khan, M., and Liu, S. (2024). Dissecting gastric cancer heterogeneity and exploring therapeutic strategies using bulk and single-cell transcriptomic analysis and experimental validation of tumor microenvironment and metabolic interplay. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1355269"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/gutjnl-2021-326483","article-title":"Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities","volume":"72","author":"Ho","year":"2022","journal-title":"Gut"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Dong, W., Qian, X., Liu, H., Huo, J., and Wang, W. (2026). Mechanisms of Metabolic Reprogramming Regulating Immunosuppression in the Gastric Cancer Tumor Microenvironment. Biomolecules, 16.","DOI":"10.3390\/biom16010160"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s41418-024-01360-z","article-title":"CCKBR+ cancer cells contribute to the intratumor heterogeneity of gastric cancer and confer sensitivity to FOXO inhibition","volume":"31","author":"Tan","year":"2024","journal-title":"Cell Death Differ."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","article-title":"Gastric cancer immunosuppressive microenvironment heterogeneity: Implications for therapy development","volume":"10","author":"Yasuda","year":"2024","journal-title":"Trends Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41419-025-07385-7","article-title":"Overcoming immunotherapy resistance in gastric cancer: Insights into mechanisms and emerging strategies","volume":"16","author":"Luo","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-026-02572-2","article-title":"Tumor microenvironment dynamics in gastric cancer pathogenesis and therapeutic resistance","volume":"25","author":"Lu","year":"2026","journal-title":"Mol. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12943-024-02003-0","article-title":"Single-cell transcriptome analysis reveals subtype-specific clonal evolution and microenvironmental changes in liver metastasis of pancreatic adenocarcinoma and their clinical implications","volume":"23","author":"Park","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1158\/1078-0432.CCR-22-3563","article-title":"Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities","volume":"29","author":"Dai","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12943-024-02077-w","article-title":"Refining the diagnostic utility of OLFM4 in gastric cancer precursors: A call for rigorous methodologies","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00428-015-1793-9","article-title":"Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer","volume":"467","author":"Jang","year":"2015","journal-title":"Virchows Arch."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00432-011-1042-9","article-title":"OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer","volume":"137","author":"Luo","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e70096","DOI":"10.1002\/mco2.70096","article-title":"Protein palmitoylation: Biological functions, disease, and therapeutic targets","volume":"6","author":"Qian","year":"2025","journal-title":"Medcomm"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1002\/jcp.30122","article-title":"Protein palmitoylation and its pathophysiological relevance","volume":"236","author":"Jin","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00535-026-02363-y","article-title":"Targeting the ZDHHC9-mediated STAT1 palmitoylation-phosphorylation conversion inhibits gastric cancer progression","volume":"61","author":"Bai","year":"2026","journal-title":"J. Gastroenterol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41388-026-03724-w","article-title":"ZDHHC9-mediated KLF5 palmitoylation enhances the cAMP\/PKA\/CREB axis to promote colorectal cancer progression","volume":"45","author":"Zhang","year":"2026","journal-title":"Oncogene"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: Looking forward","volume":"21","author":"Chandel","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.2147\/CMAR.S251596","article-title":"Glucose Transporter-1 Cooperating with AKT Signaling Promote Gastric Cancer Progression","volume":"12","author":"Zhou","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X","article-title":"Expression of glucose transporter-1 in human gastric carcinoma: Association with tumor aggressiveness, metastasis, and patient survival","volume":"92","author":"Kawamura","year":"2001","journal-title":"Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Chen, X., Sandrine, I.K., Yang, M., Tu, J., and Yuan, X. (2024). MUC1 and MUC16: Critical for immune modulation in cancer therapeutics. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1356913"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/14728222.2023.2248376","article-title":"Update value and clinical application of MUC16 (cancer antigen 125)","volume":"27","author":"Song","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_44","first-page":"21","article-title":"The RAL signaling network: Cancer and beyond","volume":"361","author":"Apken","year":"2020","journal-title":"Int. Rev. Cell Mol. Biol."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/6\/880\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T01:17:11Z","timestamp":1781745431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/6\/880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["biom16060880"],"URL":"https:\/\/doi.org\/10.3390\/biom16060880","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}